Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia

NCT02009787 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2013-12-12

No results posted yet for this study

Summary

The investigators planned to research the effect of vitamin D supplementation as an adjuvant therapy for patients with hypercholesterolemia.

Conditions

  • Primary Hypercholesterolemia

Interventions

DRUG

vitamin D3 tablets

2000 IU vitamin D3 tablets were taken daily for 6 months

DRUG

placebo tablets

2000 IU placebo tablets were taken daily for 6 months

Sponsors & Collaborators

  • Shi Yang

    lead OTHER

Principal Investigators

  • Yu Tang Wang, M.D. · PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02009787 on ClinicalTrials.gov